➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Dow
Colorcon
Moodys
Medtronic
McKesson

Last Updated: June 17, 2021

DrugPatentWatch Database Preview

Drugs in Development Information for Seltorexant


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Seltorexant?

Seltorexant is an investigational drug.

There have been 11 clinical trials for Seltorexant. The most recent clinical trial was a Phase 1 trial, which was initiated on August 31st 2020.

The most common disease conditions in clinical trials are Depressive Disorder, Major, Depressive Disorder, and Depression. The leading clinical trial sponsors are Janssen Research & Development, LLC, Minerva Neurosciences, and [disabled in preview].

There are four US patents protecting this investigational drug and fifty-nine international patents.

Recent Clinical Trials for Seltorexant
TitleSponsorPhase
A Study to Evaluate the Effect of Renal Impairment on JNJ-42847922 in Adult ParticipantsJanssen Research & Development, LLCPhase 1
A Study of Seltorexant in Healthy ParticipantsJanssen Research & Development, LLCPhase 1
A Study of Seltorexant as Adjunctive Therapy to Antidepressants in Adult and Elderly Participants With Major Depressive Disorder With Insomnia Symptoms Who Have Responded Inadequately to Antidepressant and Long-term Safety Extension Treatment With SJanssen Research & Development, LLCPhase 3

See all Seltorexant clinical trials

Clinical Trial Summary for Seltorexant

Top disease conditions for Seltorexant
Top clinical trial sponsors for Seltorexant

See all Seltorexant clinical trials

US Patents for Seltorexant

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Seltorexant   Get Started Free Methods of treating depression using orexin-2 receptor antagonists Janssen Pharmaceutica NV (Beerse, BE)   Get Started Free
Seltorexant   Get Started Free Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica (BE)   Get Started Free
Seltorexant   Get Started Free Disubstituted octahydropyrrolo[3,4-c]pyrroles as orexin receptor modulators Janssen Pharmaceutica NV (BE)   Get Started Free
Seltorexant   Get Started Free Disubstituted octahydropyrrolo [3,4-C] pyrroles as orexin receptor modulators Janssen Pharmaceutica NV (Beerse, BE)   Get Started Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Seltorexant

Drugname Country Document Number Estimated Expiration Related US Patent
Seltorexant Argentina AR078731 2029-10-23   Get Started Free
Seltorexant Argentina AR114667 2029-10-23   Get Started Free
Seltorexant Australia AU2010310595 2029-10-23   Get Started Free
Seltorexant Australia AU2015242975 2029-10-23   Get Started Free
Seltorexant Brazil BR112012010820 2029-10-23   Get Started Free
Seltorexant Canada CA2778484 2029-10-23   Get Started Free
Seltorexant Chile CL2010001162 2029-10-23   Get Started Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Express Scripts
Moodys
Boehringer Ingelheim
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.